Paula H. Cholmondeley - 25 Nov 2024 Form 4 Insider Report for Lexeo Therapeutics, Inc. (LXEO)

Role
Director
Signature
/s/ Youjin Choi, Attorney-in-Fact
Issuer symbol
LXEO
Transactions as of
25 Nov 2024
Net transactions value
+$104,852
Form type
4
Filing time
26 Nov 2024, 17:00:06 UTC
Previous filing
27 Jun 2024
Next filing
30 Jun 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LXEO Common Stock Purchase $104,852 +15,000 +96% $6.99 30,627 25 Nov 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 15,627 of the shares are subject to vesting and vest at the following rate: 1/48th of the shares vested or vest in monthly installments commencing on December 1, 2021, subject to the Reporting Person's continuous service.